학술논문

Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Document Type
Author
Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. Electronic address: richard.sylvester@skynet.be.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Max Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Hentschel AE; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Cussenot O; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Evert M; Department of Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Kiemeney LALM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Dominguez-Escrig JL; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Burger M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zigeuner R; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Mostafid AH; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; van Rhijn BWG; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
Source
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: PubMed not MEDLINE; MEDLINE
Subject
Language
English